Céline WOLF, Director of the Bertin Instruments Business Unit in charge of the Nuclear Market
17 Apr 2024
Bertin Technologies is delighted to welcome Céline WOLF as Director of the Bertin Instruments Business Unit in charge of the Nuclear Market.
Interested in : Application Push Business cases Events News Non classé Press releases
17 Apr 2024
Bertin Technologies is delighted to welcome Céline WOLF as Director of the Bertin Instruments Business Unit in charge of the Nuclear Market.
15 Apr 2024
In a recent study in the European Journal of Pharmaceutics and Biopharmaceutics, Jochem Alsenz and Elisabeth Haenel present Precellys® Evolution homogenizer with Cryolys Evolution, a patent cooling system, as a versatile tool for improving preformulation processes in drug development.
12 Apr 2024
Bacteria are present in large numbers in livestock buildings, and can threaten animal and public health. Antimicrobial resistance (AMR) is a major concern worldwide, and national measures based on the “One Health” approach are being implemented in many countries.
28 Mar 2024
Cortisol is the stress hormone. This makes it an ideal biomarker for the study of long-term stress. Researchers suggest that the average concentration of cortisol in the hair of healthy, low-stress individuals is 55pg/mhair (range 40-128pg/mhair). In stressed individuals it is 250pg/mhair (range 182-520pg/mhair).
20 Mar 2024
In a recent exclusive interview with DailyCSR, Kirsi Hedman, Business Unit Manager, and Julie Gay, HR Director, provide insights into their roles and perspectives within the Bertin Technologies Group.
08 Mar 2024
General Fusion, an international leader in the development of Magnetized Target Fusion (MTF) technology, has selected Bertin Technologies to support the design of key diagnostics for the company’s Lawson Machine 26 (LM26). Bertin Technologies’ globally recognized experts in optical systems are contributing their expertise to a new, transformative fusion demonstration, paving the way for commercial […]
26 Feb 2024
On January 25, 2024, Bertin Technologies achieved an important milestone in its history by achieving the EN9100 certification for its production site in Pertuis, located in Vaucluse. A mark of quality, this certification demonstrates its commitment to meeting the requirements of major customers in terms of management system, for the continuous improvement of its processes […]
05 Feb 2024
Colorectal cancer affects the colon or rectum and is on the rise among young adults. Lifestyle factors like diet and physical inactivity may contribute to its incidence. Early detection through regular screenings is crucial for effective management. Awareness of symptoms and risk factors is essential for timely intervention. The 4th of February marks the World […]
18 Jan 2024
Exposure to pathogenic airborne microorganisms has been associated with several human diseases. Given the role and characteristics of bioaerosols in mediating health outcomes, it is critical to determine the concentrations, diversity, and composition of bioaerosols in ambient air. The prevalence of multi-drug resistant bacteria is another dimension of important health issues related to bioaerosols. In […]
11 Dec 2023
Just a year ago, Bertin Technologies delivered to ITER Organization the final design of the Density Interferometer Polarimeter (DIP), a complex optical system for measuring plasma density during nuclear fusion reaction. Since then, our team initiated a vast program of R&D to characterize and evaluate the performance of the dispersion interferometer. Take a closer look […]
ANY QUESTIONS? CONTACT AN EXPERT
Please fill in this form if you wish to contact our sales team or receive further information.
Add a question !